InChI=1S/C28H35N5O5/c1- 33- 23- 9- 8- 20(14- 26(34) 31- 15- 18- 5- 3- 2- 4- 6- 18) 38- 25(23) 17- 37- 24- 10- 7- 19(13- 21(24) 28(33) 36) 32- 27(35) 22- 16- 29- 11- 12- 30- 22/h7,10- 13,16,18,20,23,25H,2- 6,8- 9,14- 15,17H2,1H3,(H,31,34) (H,32,35) /t20- ,23- ,25+/m1/s1 |
KUAQBUHJEIVZQC-XRODADMRSA-N |
CN1[C@@H]2CC[C@@H](O[C@H]2COC3=C(C1=O)C=C(C=C3)NC(=O)C4=NC=CN=C4)CC(=O)NCC5CCCCC5 |
|
Outgoing
|
N- [(2R,4aR,12aR)- 2- [2- (cyclohexylmethylamino)- 2- oxoethyl]- 5- methyl- 6- oxo- 2,3,4,4a,12,12a- hexahydropyrano[2,3- c][1,5]benzoxazocin- 8- yl]- 2- pyrazinecarboxamide
(CHEBI:100012)
is a
pyrazines
(CHEBI:38314)
N- [(2R,4aR,12aR)- 2- [2- (cyclohexylmethylamino)- 2- oxoethyl]- 5- methyl- 6- oxo- 2,3,4,4a,12,12a- hexahydropyrano[2,3- c][1,5]benzoxazocin- 8- yl]- 2- pyrazinecarboxamide
(CHEBI:100012)
is a
secondary carboxamide
(CHEBI:140325)
N- [(2R,4aR,12aR)- 2- [2- (cyclohexylmethylamino)- 2- oxoethyl]- 5- methyl- 6- oxo- 2,3,4,4a,12,12a- hexahydropyrano[2,3- c][1,5]benzoxazocin- 8- yl]- 2- pyrazinecarboxamide
(CHEBI:100012)
is a
tertiary carboxamide
(CHEBI:140326)
|
|
|